Table 2. Prevalence of Metabolic Syndrome in Men and Women According to GGT Quartile.
GGT, IU/L | P for trend | ||||
---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | ||
Men | Q1 (20≤) | Q2 (21–29) | Q3 (30–46) | Q4 (≥47) | |
Prevalence | 2,061 (14.0) | 3,435 (24.0) | 4,546 (33.0) | 6,264 (43.8) | <0.001 |
Model 1 | Reference | 1.988 (1.871–2.112) | 3.136 (2.957–3.327) | 5.043 (4.760–5.342) | |
Model 2 | Reference | 2.027 (1.907–2.154) | 3.251 (3.063–3.451) | 5.320 (5.014–5.645) | |
Model 3 | Reference | 1.534 (1.432–1.643) | 1.939 (1.811–2.076) | 2.754 (2.572–2.948) | |
Women | Q1 (12≤) | Q2 (13–16) | Q3 (17–23) | Q4 (≥24) | |
Prevalence | 3,392 (11.4) | 5,233 (16.0) | 7,640 (25.3) | 10,495 (36.1) | <0.001 |
Model 1 | Reference | 1.387 (1.322–1.455) | 2.329 (2.226–2.438) | 3.867 (3.700–4.042) | |
Model 2 | Reference | 1.395 (1.330–1.463) | 2.354 (2.250–2.464) | 3.934 (3.763–4.112) | |
Model 3 | Reference | 1.155 (1.094–1.218) | 1.528 (1.451–1.609) | 2.022 (1.921–2.128) |
Values are expressed as number (%) or adjusted odds ratio (95% confidence interval). Model 1: age-adjusted; Model 2: Model 1 plus adjustment for alcohol and smoking; Model 3: Model 2 plus adjustment for weight, blood pressure, and fasting plasma glucose.
GGT, gamma-glutamyltransferase.